← Open Payments lookup

CARMENCITA TEXON: Open Payments

NPI 1225725328 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$642 in 25 payments from 10 companies in 2025. Trend: 2023 $337 · 2024 $787 · 2025 $642

Food & beverage: $642
CompanyPaymentsAmount
ABBVIE INC.8$139
Intercept Pharmaceuticals, Inc.1$118
Regeneron Healthcare Solutions, Inc.4$101
Takeda Pharmaceuticals U.S.A., Inc.3$78
GENZYME CORPORATION2$49
Janssen Biotech, Inc.2$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
Medtronic, Inc.1$24
Phathom Pharmaceuticals, Inc.1$22
Madrigal Pharmaceuticals1$22

Products named: DUPIXENT, OCALIVA, LINZESS, ENTYVIO, TREMFYA, RINVOQ, GATTEX, MANOSCAN.

Industry payments across TX — which companies pay providers there.